Company Filing History:
Years Active: 2021-2024
Title: Innovations by Per Bo Pedersen Fischer
Introduction
Per Bo Pedersen Fischer is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of four patents to his name, Fischer's work focuses on developing immunogenic products and methods for preventing group B infections.
Latest Patents
Fischer's latest patents include an immunogenic fusion protein that comprises a first amino acid sequence with at least 80% sequence identity to the N-terminal region of a first group B surface protein. This protein is fused to a second amino acid sequence with similar identity to a second group B surface protein. The invention also includes an isolated nucleotide sequence encoding the immunogenic fusion protein, a vector, a host cell, and a vaccine aimed at preventing or treating group B infections. Another significant patent is an immunogenic complex that combines an amino acid sequence with a capsular polysaccharide, capable of eliciting protective immunity against group B. This complex is also associated with methods for preventing or treating group B infections.
Career Highlights
Fischer is currently associated with Minervax ApS, a company dedicated to advancing vaccine technology. His work at Minervax has been instrumental in developing innovative solutions for infectious diseases, particularly those caused by group B pathogens.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Per Bo Pedersen Fischer's contributions to immunology through his patents reflect his commitment to advancing medical science. His innovative approaches to vaccine development are paving the way for new treatments against group B infections.